Acute sore throat

Cards (11)

  • Clarithromycin dosing:
    • In adults: 250 to 500 mg twice daily for 5 days
    • In children aged 1 month to 11 years:
    • Up to 8 kg: 7.5 mg/kg twice daily for 5 days
    • 8-11 kg: 62.5 mg twice daily for 5 days
    • 12-19 kg: 125 mg twice daily for 5 days
    • 20-29 kg: 187.5 mg twice daily for 5 days
    • 30-40 kg: 250 mg twice daily for 5 days
    • In children aged 12-17 years: 250-500 mg twice daily for 5 days
  • Erythromycin dosing for pregnant women:
    • 250 mg to 500 mg four times daily or 500 mg to 1,000 mg twice daily for 5 days
  • Contraindications and cautions for clarithromycin and erythromycin:
    • Do not prescribe to people at risk of QT prolongation
    • Do not prescribe to people with severe hepatic impairment in combination with renal impairment
    • Prescribe with caution to people with myasthenia gravis, mild to moderate hepatic impairment, coronary artery disease, severe cardiac insufficiency, or bradycardia
    • Adjust dose based on creatinine clearance
  • Drug interactions with clarithromycin and erythromycin:
    • Carbamazepine: reduce dose by 30–50%
    • Corticosteroids: monitor for increased levels
    • Lomitapide: contraindicated with erythromycin
    • Rivaroxaban: erythromycin may increase levels
    • Warfarin: monitor INR and adjust dose
    • Statins: increased risk of myopathy
    • Calcium channel blockers: caution advised
    • Drugs that prolong the QT interval: avoid concomitant use
    • Theophylline: monitor levels and adjust dose
  • Adverse effects of macrolides:
    • Nausea, vomiting, abdominal discomfort, and diarrhea are common
    • Consider pseudomembranous colitis if severe diarrhea occurs
    • Anaphylaxis, hepatotoxicity, rash, reversible hearing loss, pancreatitis, QT interval prolongation, arrhythmias, Stevens-Johnson syndrome, and toxic epidermal necrolysis are rare adverse effects
  • Dosage for adults:
    • 500 mg four times daily, or 1000 mg twice daily (can be increased up to 1000 mg four times daily) for 5 to 10 days
  • Dosage for children for phenoxymethylpenicillin:
    • 1-11 months: 62.5 mg 4 times daily, or 125 mg twice daily for 5 to 10 days
    • 1-5 years: 125 mg 4 times daily, or 250 mg twice daily for 5 to 10 days
    • 6-11 years: 250 mg 4 times daily, or 500 mg twice daily for 5 to 10 days
    • 12-17 years: 500 mg 4 times daily, or 1000 mg twice daily for 5 to 10 days
  • A 5-day course may be sufficient for symptomatic cure, while a 10-day course may increase the chance of microbiological cure
  • Contraindications and cautions:
    • Do not prescribe penicillin to individuals with a history of anaphylaxis, urticaria, or rash immediately after penicillin administration due to the risk of immediate hypersensitivity
    • People with a history of a minor rash or a rash occurring more than 72 hours after penicillin administration are likely not allergic to penicillin and should not have penicillin withheld unnecessarily for serious infections
    • Prescribe penicillins with caution to individuals with a history of atopic allergy or cephalosporin-sensitivity
  • Adverse effects of penicillins:
    • Common adverse effects include diarrhoea, fever, hypersensitivity reactions, joint pain, rash, serum sickness-like reaction, and urticaria
    • Rare adverse effects include anaphylaxis, angioedema, cerebral irritation, CNS toxicity, coagulation disorders, encephalopathy, haemolytic anaemia, interstitial nephritis, leucopenia, thrombocytopenia, and neutropenia
  • Drug interactions with phenoxymethylpenicillin:
    • Neomycin reduces absorption of phenoxymethylpenicillin
    • Coumarins can alter INR with current penicillin use
    • Methotrexate excretion is reduced by penicillins, leading to increased risk of toxicity
    • Sulfinpyrazone reduces excretion of penicillins
    • Tetracyclines may antagonize the effects of penicillins
    • Oral contraceptives' effectiveness may be impaired by phenoxymethylpenicillin, necessitating additional forms of contraceptives
    • Potassium-sparing diuretics (amiloride or spironolactone) may lead to life-threatening hyperkalaemia